Sabra Health Care REIT Inc
NASDAQ:SBRA

Watchlist Manager
Sabra Health Care REIT Inc Logo
Sabra Health Care REIT Inc
NASDAQ:SBRA
Watchlist
Price: 20.735 USD 0.17% Market Closed
Market Cap: $5.2B

Wall St Price Targets

SBRA Price Targets Summary
Sabra Health Care REIT Inc

Wall Street analysts forecast SBRA stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for SBRA is 23.023 USD with a low forecast of 19.19 USD and a high forecast of 26.25 USD.

Lowest Forecast
Price Target
19.19 USD
7% Downside
Average Forecast
Price Target
23.023 USD
11% Upside
Highest Forecast
Price Target
26.25 USD
27% Upside
Sabra Health Care REIT Inc Competitors:
Price Targets
WERN
Werner Enterprises Inc
13% Upside
DK
Delek US Holdings Inc
-14% Downside
UHT
Universal Health Realty Income Trust
8% Upside
LTC
LTC Properties Inc
12% Upside
EFX
Equifax Inc
10% Upside
UE
Urban Edge Properties
16% Upside
CHCT
Community Healthcare Trust Inc
23% Upside

Revenue
Forecast

17% / Year
Past Growth
12% / Year
Estimated Growth
Estimates Accuracy
1%
Average Beat
17% / Year
Past Growth
12% / Year
Estimated Growth
Estimates Accuracy
1%
Average Beat

Over the last 13 years, the compound annual growth rate for Revenue has been 17%. The projected CAGR for the next 6 years is 12%.

Gross Profit
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
Gross Profit Forecast
is not available for Sabra Health Care REIT Inc

Operating Income
Forecast

13% / Year
Past Growth
13% / Year
Estimated Growth
Estimates Accuracy
4%
Average Beat
13% / Year
Past Growth
13% / Year
Estimated Growth
Estimates Accuracy
4%
Average Beat

Over the last 13 years, the compound annual growth rate for Operating Income has been 13%. The projected CAGR for the next 6 years is 13%.

Pre-Tax Income
Forecast

17% / Year
Past Growth
13% / Year
Estimated Growth
Estimates Accuracy
-5%
Average Miss
17% / Year
Past Growth
13% / Year
Estimated Growth
Estimates Accuracy
-5%
Average Miss

Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 17%. The projected CAGR for the next 3 years is 13%.

Net Income
Forecast

17% / Year
Past Growth
14% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss
17% / Year
Past Growth
14% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Over the last 13 years, the compound annual growth rate for Net Income has been 17%. The projected CAGR for the next 6 years is 14%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is SBRA's stock price target?
Price Target
23.023 USD

According to Wall Street analysts, the average 1-year price target for SBRA is 23.023 USD with a low forecast of 19.19 USD and a high forecast of 26.25 USD.

What is the Revenue forecast for Sabra Health Care REIT Inc?
Projected CAGR
12%

Over the last 13 years, the compound annual growth rate for Revenue has been 17%. The projected CAGR for the next 6 years is 12%.

What is the Operating Income forecast for Sabra Health Care REIT Inc?
Projected CAGR
13%

Over the last 13 years, the compound annual growth rate for Operating Income has been 13%. The projected CAGR for the next 6 years is 13%.

What is the Pre-Tax Income forecast for Sabra Health Care REIT Inc?
Projected CAGR
13%

Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 17%. The projected CAGR for the next 3 years is 13%.

What is the Net Income forecast for Sabra Health Care REIT Inc?
Projected CAGR
14%

Over the last 13 years, the compound annual growth rate for Net Income has been 17%. The projected CAGR for the next 6 years is 14%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett